PCRX Financials

Pacira Biosciences Inc - Financial statements & key metrics

Stock Price

$23.86

Market Cap

$1.03B

P/E Ratio

149.1

EPS

$0.16

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-99.56M

EPS (Diluted)

$-2.15

Balance Sheet Highlights

Total Assets

$1.55B

Total Liabilities

$775.17M

Shareholders Equity

Cash & Equivalents

$276.77M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$189.39M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

63.2%

Operating Margin

-0.0%

Net Margin

0.0%

ROE

0.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PCRX revenue?

View PCRX's income statement for detailed revenue data.

Is PCRX profitable?

PCRX reported a loss of $99.56M in the most recent quarter. The net profit margin is 0.0%.

What is PCRX market cap?

PCRX has a market capitalization of $1.03B, making it a small-cap stock.

Does PCRX have debt?

View PCRX's balance sheet for debt information.

What is PCRX cash flow?

Cash flow data is available in the full financial statements.